GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
MFEJX
Price
$170.09
Change
-$10.08 (-5.59%)
Updated
Apr 3 closing price
Net Assets
42.45B
Ad is loading...

GFACX vs MFEJX

Header iconGFACX vs MFEJX Comparison
Open Charts GFACX vs MFEJXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
MFS Growth R4
Price$170.09
Change-$10.08 (-5.59%)
VolumeN/A
Net Assets42.45B
GFACX vs MFEJX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MFEJX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MFEJX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. MFEJX (42.4B). MFEJX pays higher dividends than GFACX: MFEJX (0.06) vs GFACX (0.00). GFACX was incepted earlier than MFEJX: GFACX (24 years) vs MFEJX (20 years). GFACX (1.36) is less costly to investors than MFEJX (0.61). MFEJX is a more actively managed with annual turnover of: 33.00 vs. GFACX (25.00). MFEJX has a lower initial minimum investment than GFACX: MFEJX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. MFEJX (-6.82). MFEJX return over 5 years is better than : 71.63 vs. GFACX (59.73).
GFACXMFEJXGFACX / MFEJX
Total Expense Ratio1.360.60227%
Annual Report Gross Expense Ratio1.360.61223%
Fund Existence24 years20 years-
Gain YTD-5.003-7.35868%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets280B42.4B660%
Annual Yield % from dividends0.000.06-
Returns for 1 year-1.75-6.8226%
Returns for 3 years0.637.079%
Returns for 5 years59.7371.6383%
Returns for 10 years44.46149.1130%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences